Editor of Patient Care Online.
Awareness of Lung Cancer Screening Remains Low in US: Daily Dose
Your daily dose of the clinical news you may have missed.
New Review Highlights Need to Address Sleep Disturbances in Patients with Dementia
Review authors emphasized the need for a more comprehensive approach to dementia management.
Counseling Patients on False Positives in cfDNA Blood-Based Colorectal Cancer Screening
William Grady, MD, highlights ongoing efforts to improve test sensitivity and developments of new blood-based tests for early detection of CRC.
New Trial Backs Intensive Blood Pressure Target for Adults with T2D: Daily Dose
Pandemic Medical Misinformation Has Not Prompted Disciplinary Action: Daily Dose
Colorectal Cancer Screening: Considerations for Using Cell-Free DNA Blood Tests in Older Adults
William Grady, MD, coauthor of the ECLIPSE study, discusses the use of non-invasive cfDNA blood-based tests for CRC screening in older adults.
Long-Term Study Provides Insights into Cognitive Aging: Daily Dose
The Future of GLP-1RAs in Obesity Treatment: Expert Perspective
With the recent surge in demand and supply shortages, Michael Crotty, MD, discusses the future of GLP-1RA use in the treatment of obesity.
How Primary Care Physicians Can Approach the Use of GLP-1 Receptor Agonists for Weight Loss
Michael Crotty, MD, provides practical guidance for on integrating GLP-1 receptor agonists into a comprehensive obesity treatment plan.
GLP-1RAs for Weight Management: Weighing Benefits vs Side Effects
Obesity medicine specialist Michael Crotty, MD, discusses the benefits of GLP-1 receptor agonist use in weight management and its impact on obesity-related comorbidities.
CDC Releases Annual STI Report: Daily Dose
Amgen Reports Promising Phase 2 Data on MariTide for Obesity, Type 2 Diabetes Management
The investigational weight loss drug showed substantial weight loss among people with obesity or overweight with or without T2D without plateaus.
USPSTF Reaffirms Syphilis Screening for Pregnant Individuals Amid Rising Congenital Syphilis Rates
Comments on the draft recommendation can be submitted through December 23, 2024.
Sex-Specific Dementia Risk in Older Adults with OSA: Daily Dose
GLP-1RAs, SGLT2is Cut Risk of Future MI, Stroke in Survivors: Daily Dose
Colorectal Cancer: How a New Blood-Based DNA Test Stacks Up in Screening Options
William Grady, MD, coauthor of the ECLIPSE trial, discusses how the Shield cfDNA blood-based test compares to traditional CRC screening methods.
Advantages of Blood-Based Colorectal Cancer Screening: An Expert Discussion
William Grady, MD, highlights the convenience and compliance of blood-based tests compared to colonoscopy and stool-based tests for colorectal cancer screening.
US Trends in Obesity-Related Ischemic Heart Disease Mortality: Daily Dose
Expanding the Obesity Treatment Toolbox: The Promise of Dual-Action Medications
Michael Crotty, MD, an expert in obesity medicine, discusses GLP-1RAs in the context of weight loss, including the novel dual agonist survodutide.
Sharp Rise in Early-Onset Colorectal Cancer Mortality Among Young US Adults: Daily Dose
New UTI Guideline Offers Treatment Clarity, but Reveals Pressing Gaps in Research
The recommendations from WikiGuidelines are the first for UTI prevention, diagnosis, and management in over a decade.
Metabolic Bariatric Surgery Takes a Backseat as GLP-1RA Use Rises: Daily Dose
ECLIPSE Trial of Cell-Free DNA Blood-Based CRC Screening Test: Expert Overview
William Grady, MD, coauthor of the ECLIPSE clinical trial, discusses the study's rationale, methods, and key findings.
The Liver Meeting 2024: Bausch Health Presents Phase 3 Study Design for Investigational Rifaximin Formulation to Delay OHE
The RED-C clinical trial program highlights the promising potential of the rifaximin soluble solid dispersion immediate-release tablets for delaying early HE-related decompensation.
Aprocitentan Now Available in the US for Treatment-Resistant Hypertension
Aprocitentan is the first-and-only dual endothelin receptor antagonist approved for the treatment of systemic hypertension.
FDA Accepts Dupilumab sBLA for Review for Treatment of Chronic Spontaneous Urticaria
The target action date for the FDA decision is April 18, 2025, according to Sanofi and Regeneron.
Semaglutide 2.4 mg Cuts Hospitalization Risk in CVD, Obesity: Daily Dose
7 Questions on US STI Trends
The CDC just released its annual STD surveillance report. Are you caught up on the latest trends? Try your hand at these 7 questions to find out.
GLP-1RAs Cut Early Colorectal Cancer Risk in Adults with T2D: Daily Dose
STI Epidemic in US Shows Signs of Slowing, According to New CDC Report
More than 2.4 million STIs were reported in the US in 2023 — a 1.8% decrease from 2022, according to the CDC's annual STI report.
